Orally active protease inhibitor. Inhibits trypsin and various inflammatory proteases including plasmin, kallikrein and thrombin. Suppresses pancreatitis-induced pain in rats following oral administration. Also inhibits transmembrane serine protease TMPRSS2 and partially blocks entry of SARS-Cov-2 (COVID-19) into lung cells in vitro. Reported use in Covid-19 Research.
Biochemicals & Diagnostics
|Appearance||white to off-white powder|
|Storage Conditions||Room temperature|
|MDL Number||Request if not shown|
Send us your enquiry for Camostat Mesylate. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Camostat Mesylate email us and we will include your contribution on the website.